Dr. Amy liao
Co-Founder and Chief Executive Officer
Couragene
Amy Liao is the co-founder and chief executive officer of Couragene, a role she has
held since the company's inception in 2022.
Prior to starting Couragene, Liao was a co-founder and CEO of GENEWIZ, and then president of Brooks Life Sciences Services after GENEWIZ was acquired by Brooks Automation. She has had a long and distinguished career in genomics services and sciences, with many academic and business achievements to date.
In 2020, Liao received the coveted Biomedical Engineering Society's Wallace A. Coulter award for innovation in healthcare, in honor of her lifetime commitment and important contributions to patient healthcare. In 2010, along with Dr. Steve Sun, co-founder of GENEWIZ, she received the Ernst & Young Entrepreneur of the Year® 2010 Award in the Services category for New Jersey.
Liao graduated with a bachelor's degree from Nankai University, a master's degree from Tsinghua University, and a PhD in Biochemistry and Cell Biology from Stony Brook University. She carried out her postdoctoral studies at Columbia University before co-founding GENEWIZ with her business partner in 1999.